Market Value554,995,000
Total Holdings72
File Date2021-05-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RNA / Avidity Biosciences, Inc.
RVNC / Revance Therapeutics, Inc.
NTRA / Natera, Inc.
ABBV / AbbVie Inc.
MSON / Misonix Inc
US0153511094 / Alexion Pharmaceuticals, Inc.
OSH / Oak Street Health Inc
LNTH / Lantheus Holdings, Inc.
MDNA / Medicenna Therapeutics Corp
FLXN / Horizon Funds - Horizon Flexible Income ETF
MDXG / MiMedx Group, Inc.
US92538T1043 / VESPER HEALTHCARE ACQUISITION CORP A
KDMN / Kadmon Holdings Inc
NVTA / Invitae Corporation
PRVB / Provention Bio Inc
MRSN / Mersana Therapeutics, Inc.
NVRO / Nevro Corp.
CUTR / Cutera, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
TPTX / Turning Point Therapeutics Inc
US10806XAB82 / Bridgebio Pharma, Inc.
HZNP / Horizon Therapeutics Plc
ZYME / Zymeworks Inc.
MORF / Morphic Holding, Inc.
KNTE / Kinnate Biopharma Inc.
US4330001144 / Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A at an
KYMR / Kymera Therapeutics, Inc.
RFL / Rafael Holdings, Inc.
SRDX / Surmodics, Inc.
SRRK / Scholar Rock Holding Corporation
STAA / STAAR Surgical Company
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
OCX / OncoCyte Corporation
US38341PAA03 / Gossamer Bio Inc
/ RENALYTIX AI PLC-ADR DEPOSITARY RECEIPT
TARA / Protara Therapeutics, Inc.
PAYX / Paychex, Inc.
VCEL / Vericel Corporation
MGTA / Magenta Therapeutics Inc
IRMD / IRADIMED CORPORATION
CMAX / CareMax, Inc.
MRK / Merck & Co., Inc.
TRIL / Trillium Therapeutics Inc
ATXS / Astria Therapeutics, Inc.
PHG / Koninklijke Philips N.V. - Depositary Receipt (Common Stock)
DRIO / DarioHealth Corp.
NVCR / NovoCure Limited
GLTO / Galecto, Inc.
ONCR / Oncorus, Inc.
TCRR / Tcr2 Therapeutics Inc
DYN / Dyne Therapeutics, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
CRDF / Cardiff Oncology, Inc.
ASMB / Assembly Biosciences, Inc.
INBX / Inhibrx Biosciences, Inc.
SIEN / Sientra, Inc.
PIRS / Pieris Pharmaceuticals, Inc.
ADVM / Adverum Biotechnologies, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
HIMS / Hims & Hers Health, Inc.
DXCM / DexCom, Inc.
MRTX / Mirati Therapeutics, Inc.
NEO / NeoGenomics, Inc.
ESTA / Establishment Labs Holdings Inc.
CRSP / CRISPR Therapeutics AG
EIGR / Eiger BioPharmaceuticals, Inc.
FATE / Fate Therapeutics, Inc.
THTX / Theratechnologies Inc.
XENE / Xenon Pharmaceuticals Inc.
NARI / Inari Medical, Inc.
AXGN / Axogen, Inc.
BIIB / Biogen Inc.
EXEL / Exelixis, Inc.
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
RVMD / Revolution Medicines, Inc.
EWTX / Edgewise Therapeutics, Inc.
ISEE / IVERIC bio Inc
BCAB / BioAtla, Inc.
SPRY / ARS Pharmaceuticals, Inc.
CCCC / C4 Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
EPIX / ESSA Pharma Inc.
BHVN / Biohaven Ltd.
ALPN / Alpine Immune Sciences, Inc.
KRYS / Krystal Biotech, Inc.
PCVX / Vaxcyte, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
LYRA / Lyra Therapeutics, Inc.